Yubo Wang

1.4k total citations
70 papers, 965 citations indexed

About

Yubo Wang is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Yubo Wang has authored 70 papers receiving a total of 965 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Pulmonary and Respiratory Medicine, 19 papers in Oncology and 17 papers in Molecular Biology. Recurrent topics in Yubo Wang's work include Meningioma and schwannoma management (6 papers), Glioma Diagnosis and Treatment (5 papers) and Health Systems, Economic Evaluations, Quality of Life (5 papers). Yubo Wang is often cited by papers focused on Meningioma and schwannoma management (6 papers), Glioma Diagnosis and Treatment (5 papers) and Health Systems, Economic Evaluations, Quality of Life (5 papers). Yubo Wang collaborates with scholars based in China, United States and United Kingdom. Yubo Wang's co-authors include Yacine Aı̈t-Sahalia, Patrick J. DiMario, Allison James, Himanshu Raje, Hui Zhang, Yanling Yin, Wenzhi Guo, Li Ma, Yong He and Peng Hou and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Yubo Wang

61 papers receiving 931 citations

Peers

Yubo Wang
Ke Wu China
Yu‐Li Su Taiwan
Ahmad Shariftabrizi United States
Jiaqi Zhu United States
Zhiyong Liu China
Qiyu Zhang China
Xiaoyan Cheng China
Sahar Barjesteh van Waalwijk van Doorn-Khosrovani Netherlands
Che Zhang China
Ke Wu China
Yubo Wang
Citations per year, relative to Yubo Wang Yubo Wang (= 1×) peers Ke Wu

Countries citing papers authored by Yubo Wang

Since Specialization
Citations

This map shows the geographic impact of Yubo Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yubo Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yubo Wang more than expected).

Fields of papers citing papers by Yubo Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yubo Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yubo Wang. The network helps show where Yubo Wang may publish in the future.

Co-authorship network of co-authors of Yubo Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Yubo Wang. A scholar is included among the top collaborators of Yubo Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yubo Wang. Yubo Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Yu, Xiao, et al.. (2025). Respiratory diseases and the gut microbiota: an updated review. Frontiers in Cellular and Infection Microbiology. 15. 1629005–1629005. 2 indexed citations
3.
Wang, Yubo, et al.. (2024). Health state utility values of type 2 diabetes mellitus and related complications: a systematic review and meta-regression. Health and Quality of Life Outcomes. 22(1). 74–74. 1 indexed citations
4.
5.
Qian, Xin, et al.. (2024). Turn TRAIL Into Better Anticancer Therapeutic Through TRAIL Fusion Proteins. Cancer Medicine. 14(1). e70517–e70517. 1 indexed citations
6.
Huang, Yueting, et al.. (2024). Efficacy and safety of PARP inhibitors in the treatment of prostatic cancer: a systematic review and network meta-analysis. Chinese Clinical Oncology. 13(4). 64–64. 2 indexed citations
7.
Li, Jinyan, Jun Fu, Yubo Wang, et al.. (2023). Melatonin improves cholestatic liver disease via the gut‐liver axis. Journal of Pineal Research. 76(1). e12929–e12929. 14 indexed citations
8.
Xu, Haiyang, et al.. (2023). Epidemiology and survival of patients with central nervous system solitary fibrous tumors: A population-based analysis. Frontiers in Oncology. 12. 977629–977629. 4 indexed citations
9.
Wang, Yubo, Sean P. Gavan, Douglas Steinke, Kwok‐Leung Cheung, & Li‐Chia Chen. (2022). The impact of age on health utility values for older women with early-stage breast cancer: a systematic review and meta-regression. Health and Quality of Life Outcomes. 20(1). 169–169. 5 indexed citations
10.
Wang, Yubo, Sean P. Gavan, Douglas Steinke, Kwok‐Leung Cheung, & Li‐Chia Chen. (2022). Systematic review of the evidence sources applied to cost-effectiveness analyses for older women with primary breast cancer. Cost Effectiveness and Resource Allocation. 20(1). 9–9. 1 indexed citations
11.
12.
Yang, Xiaochen, Yubo Wang, Geng Chen, & Xinyu Hong. (2022). Multifocal primary intracranial yolk sac tumor in an adult patient: a case report and literature review. Translational Cancer Research. 11(5). 1429–1433. 1 indexed citations
13.
Wang, Yubo, et al.. (2022). Case Report: Trigeminocardiac Reflex in Endovascular Recanalization of Intracranial Internal Carotid Artery Occlusion. Frontiers in Neurology. 13. 902620–902620. 1 indexed citations
14.
Liu, Zhendong, Binfeng Liu, Hongbo Wang, et al.. (2021). ITGB3BP is a potential biomarker associated with poor prognosis of glioma. Journal of Cellular and Molecular Medicine. 26(3). 813–827. 3 indexed citations
15.
Wu, Dongdong, Juan Li, Yubo Wang, Hao Huang, & Chunji Huang. (2021). Cost-effectiveness analysis of neoadjuvant versus adjuvant chemotherapy for cT2-4N0-1 non-small cell lung cancer patients during initial treatment phase. Cost Effectiveness and Resource Allocation. 19(1). 44–44. 3 indexed citations
16.
Wang, Yubo, et al.. (2020). Opinions on the corona virus disease 2019. 49. 5 indexed citations
17.
Qin, Xiaowei, Yubo Wang, Songbai Xu, & Xinyu Hong. (2019). Familial arachnoid cysts: a review of 35 families. Child s Nervous System. 35(4). 607–612. 7 indexed citations
18.
Zhang, Hui, et al.. (2016). Intracranial Clear Cell Meningiomas: Study on Clinical Features and Predictors of Recurrence. World Neurosurgery. 97. 693–700.e11. 15 indexed citations
19.
Sun, Jie, You‐Bin Deng, Kun Liu, & Yubo Wang. (2014). Effects of Noradrenaline and Adenosine Triphosphate on the Degree on Contrast Enhancement in a Rabbit Model of Atherosclerosis during Contrast-Enhanced Ultrasonography. Ultrasound in Medicine & Biology. 40(11). 2655–2661. 5 indexed citations
20.
Wang, Yubo, et al.. (2010). Poly[bis(μ-4-benzoyl-1-isonicotinoylthiosemicarbazide-κ2N:S)dichloridocadmium(II)]. Acta Crystallographica Section C Crystal Structure Communications. 66(5). m127–m129. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ke Wu Breakdown of academic impact, for papers by Yu‐Li Su Breakdown of academic impact, for papers by Ahmad Shariftabrizi Breakdown of academic impact, for papers by Jiaqi Zhu Breakdown of academic impact, for papers by Zhiyong Liu Breakdown of academic impact, for papers by Qiyu Zhang Breakdown of academic impact, for papers by Xiaoyan Cheng Breakdown of academic impact, for papers by Sahar Barjesteh van Waalwijk van Doorn-Khosrovani Breakdown of academic impact, for papers by Che Zhang
Rankless by CCL
2026